HBSP (USA)
-
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
Hamermesh, Richard G.; Kucherlapati, Raju; Gordon, RachelCase HBS-810066-EEntrepreneurshipIn May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several years prior. Moreover, Vectibix had also received Food and Drug Administration approval in 2006. During additional trials, Amgen has learned that the Vectibix...Starting at €8.20
-
The Indego Africa Project (Spanish Version)
McGinn, Kathleen L.; Gordon, RachelCase HBS-914S10Dos abogados jóvenes que se encuentran y comienzan a construir el Proyecto África Indego, una asociación de ONG con cooperativas de mujeres en Ruanda. Indego conecta las cooperativas en el mercado minorista internacional de productos artesanales hechos a mano, ayuda a las cooperativas construyen su capacidad de negocio, y desarrolla y ofrece formación en el aula en la vida y habilidades de negocio para los miembros de la cooperativa. En el moment...Starting at €8.20
-
Storming into the U.S. Market (Spanish version)
Bartlett, Christopher A.; Gordon, Rachel; Lafkas, JohnCase HBS-918S10StrategyThe RoboTech case describes the challenges facing the CEO of a small, Singapore-based industrial robotics company that decides to diversify away from its core industrial robot business by leveraging its expertise into the medical-devices industry. It launches an innovative product (a specialized surgical robot) in an unfamiliar market segment (spinal surgery) and decides to enter the unfamiliar, distant U.S. healthcare market, which is characteri...Starting at €8.20
-
Intrapreneurship within FLG, Inc. (Spanish version)
Garvin, David A.; Gordon, RachelCase HBS-918S11EntrepreneurshipThis case follows Jenica Fletcher as she rebuilds her company's guitar strings division from the ground up. Convinced that she could turn the division around if given complete independence from corporate headquarters, Fletcher relocated the group, rebranded it as Malenti Strings, repositioned the guitar strings as high-performance products, and transformed Malenti into a fast-growing, profitable business. The case traces Fletcher's key steps in...Starting at €8.20
-
Differences at Work: Alex (A) (Spanish version)
Sucher, Sandra J.; Gordon, RachelCase HBS-408S50Leadership and People ManagementIn Differences at Work: Alex (A), HBS Case No. 9-408-011 Alex has been asked an inappropriate question by the interviewer at an interview for his dream job. How will Alex handle the situation? Should he accept the position is offered?Starting at €8.20
-
Adnexus Therapeutics, Inc.: Considering the Exit
Sato, Vicki L.; Gordon, RachelCase HBS-609015-EService and Operations ManagementDr. John Mendlein, CEO of Adnexus Therapeutics Inc., (Adnexus), a private biotechnology company, must decide whether to pursue acquisition talks with Bristol-Myers Squibb (BMS) after a successful six month collaboration or continue with Adnexus' planned IPO.Starting at €8.20
-
Dartmouth-Hitchcock Medical Center: Spine Care
Huckman, Robert S.; Porter, Michael E.; Gordon, Rachel; Kindred, NatalieCase HBS-609016-EStrategyDescribes the Spine Center at Dartmouth-Hitchcock Medical Center, a multidisciplinary unit that offers patients suffering from spinal problems "one-stop" access to a range of providers including orthopedic surgeons, neurosurgeons, neurologists, medical specialists in physical medicine and pain management, mental health providers, and occupational and physical therapists. The Center was created to address what its founder, James Weinstein, M.D., s...Starting at €8.20
-
Blue Haven Initiative: The PEGAfrica Investment
Gandhi, Vikram; Reimers Brumme, Caitlin Lindsay; Migdal, AmramCase HBS-318003-EFinanceThis case examines Blue Haven Initiative (BHI), an impact investing fund and family office, and one of its investments, PEGAfrica (PEG). BHI founder Liesel Pritzker Simmons' motivations for using her family wealth to start a family office focused on impacStarting at €8.20
-
The Rise Fund: TPG Bets Big on Impact
Gandhi, Vikram; Reimers Brumme, Caitlin Lindsay; Mehta, SarahCase HBS-318041-EFinanceIt is March 2017 and TPG, a global alternative investment firm with $74 billion assets under management, has recently launched its inaugural impact investing fund-the $2 billion Rise Fund. In an effort to "take the religion out of impact investing," Mike Stone, CIO of Rise, has partnered with Chris Addy at The Bridgespan Group, a nonprofit consultancy, to develop an evidence-based methodology for quantifying the impact of prospective Rise investm...Starting at €8.20
-
Differences at Work: Alex (B)
Sucher, Sandra J.; Gordon, RachelCase HBS-408042-ELeadership and People ManagementIn Differences at Work: Alex (B) HBS Case No. 9-408-042 turns to his uncle, an employment lawyer, to discuss the situation. After receiving a matching offer from his current firm, Alex decides to stay with his firm but concedes that he did not have to make any hard ethical decisions. He wonders what he would have done if he had not received the matching offer.Starting at €5.74